Doctors asking how much post-surgical follow-up is needed
On Saturday, Reisman, 52, a former New York lawyer who now freelances for the Shoreline Times, held a party to celebrate two decades of survival. Looking back on the years after her surgery, Reisman said the fear that the cancer could return was compounded by the anxiety she felt about the multiple MRIs she was required to undergo to make sure it hadn’t. Reisman’s experience has buttressed the concern of Dr. Cary Gross, her brother-in-law, a professor of medicine and epidemiology at the Yale School of Medicine. With new studies showing that multiple surveillance procedures don’t necessarily improve patient outcomes in at least some cancers, he is concerned about whether aggressive post-treatment testing is really necessary, given the anxiety, cost and even occasional false positive results that accompany it.Source: New Haven Register
New Centers to Advance Implementation and Prevention Sciences
Two new centers at the School of Medicine and the School of Public Health will promote the adoption of research findings into clinical practice and develop and assess sustainable, cost-effective interventions to improve public health domestically and around the world.
Patients who choose alternative medicine for cancer are richer, smarter, younger and healthier - but it makes their risk of dying MUCH higher
People who choose to get alternative treatments for cancer tend to have everything else going for them - being happier, younger, wealthier, and more educated. Yet those who try to treat curable cancers with alternative medicines - including crystals and homeopathy - are 5.68 times more likely to die than people who get traditional treatments. The alternative medicine business is booming in the US, where it is worth $34 billion, even though only a third of its 'treatments' have been tested. But more highly-educated people may be sabotaging themselves by believing that they are smart enough to spot a real success story over snake oil instead of trusting doctors.Source: DailyMail
Yale Cancer Center receives $1 million grant to address cancer disparities
Researchers at Yale Cancer Center (YCC) have been awarded a $1 million grant by the Bristol-Myers Squibb Foundation (BSMF) to address health care disparities in cancer care and support. The grant will fund the Cancer Disparities Firewall project, a multilevel intervention that focuses on patient and system level factors that contribute to cancer disparities in the YCC/New Haven, Connecticut area. The project will target lung, breast, colorectal, and prostate cancer.
Can Digestive Chemistry Uncover Sex-Specific Causes of Colon Cancer?
Dr. Caroline Helen Johnson received this year’s Wendy U. and Thomas C. Naratil Pioneer Award and co-funding from the Yale Cancer Center to explore hormones and environmental factors related to metabolite production (such as sugars and amino acids) and beneficial bacteria that live in the colon as possible sources of gender difference.
Tossing Lines: A killer meets its match as cancer and charity biking collide
My bicycle may not be as magically celestial as Elliot’s flying bike in “E.T.: The Extra-terrestrial,” but it did take me on an extraordinary journey recently through Yale-New Haven Health’s huge “Closer to Free” annual charity cycling event to fight cancer. We raised $3 million for Yale’s Smilow Cancer Hospital, and donations were still coming in. On a recent Saturday, in the chilly pre-dawn darkness, I stood in a wide open space outside the Yale Bowl in New Haven.Source: The New London Day
Yale Study: Minority Breast Cancer Patients Less Likely To Have Genetic Test
A genetic test that helps doctors determine how best to treat breast cancer -- and whether chemotherapy is likely to help -- is significantly more likely to be administered to white women than blacks or Hispanics, a Yale study has found.Source: WNPR
Racial Disparities in Genetic Testing of Women With Breast Cancer
MedicalResearch.com Interview with: Cary P. Gross, MD Section of General Internal Medicine Yale University School of Medicine New Haven, CT MedicalResearch.com: What is the background for this study? What are the main findings? Response: Prior work has demonstrated racial and socioeconomic disparities in breast cancer diagnosis, treatment, and outcomes. As the oncology field has progressed over the past decade, the use of genetic testing to guide treatment decisions is one of the most exciting new developments.Source: Medical Research
Yale Study Published in JNCCN Uncovers Racial Disparities in Treatment of Women with Breast Cancer
In a simple definition, cancer is a disease of the cells, which is caused by gene mutations. For a proportion of patients, including women with hormone receptor positive (HR+) breast cancer, gene expression profiling has a substantial impact on treatment decision-making by determining which patients might—or might not—respond to particular treatment options.
New Haven cancer doctors working to draw people of color into clinical trials
Minorities make up about 10 percent to 12 percent of the participants in clinical trials at Smilow, which recruits participants from across Connecticut, said Dr. Roy Herbst, chief of medical oncology. But, given that New Haven is about two-thirds black or Hispanic, both Herbst and Silber would like to increase the number of minorities who can benefit from new drugs. “We want to bring the best care to all people; we want to bring access to all people,” said Herbst, who said he’d like to at least double the percentage of minorities in Smilow’s trials of cancer drugs.Source: New Haven Register
In their own words, cancer patients describe the experience at New Haven’s Smilow Cancer Hospital
Essays of hope, of heartache, of loss and triumph were read Tuesday during a presentation of writings by patients at Smilow Cancer Hospital. “In Our Own Words,” a program at the hospital, has given the patients an outlet, and also a chance to let others know what the cancer experience entails.Source: New Haven Register